EUVIMEDEUVIMED entdecken
Crossref

De novo SRCAP variants cause developmental and epileptic encephalopathy and the phenotypic spectrum

Xiao-Yu Liang iD, Xiang-Hong Meng iD, Wu-Chen Wu iD, Jing Guo, Sheng Luo iD, Peng-Yu Wang iD, Dong-Ming Zhang iD, Zi-Sheng Lin iD, Jin-Jie Liang iD, Su-Li He iD, Bing-Mei Li iD, Jie Wang iD und 4 weitere

Epilepsia · 2026

DOI: 10.1111/epi.18695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Xiao-Yu Liang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and Ministry of Educati…. Hauptthemen laut MEDLINE: Epilepsy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Multi-center Clinical Research Fund Project of the Second Affiliated Hospital of Guangzhou Medical University, Sanming Project of Medicine in Shenzhen "Multidisciplinary epilepsy diagnosis and treatment team of Prof.Wang Yuping from Xuanwu Hospital Capital Medical Unive….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The SRCAP gene encodes a core catalytic subunit of adenosine triphosphate‐dependent chromatin remodeling complexes that play an essential role in chromatin regulation and neurodevelopment. Our recent study showed that the EP400 gene, the paralog of SRCAP , is associated with neurodevelopmental disorders and epilepsy. This study aims to explore the relationship between SRCAP and developmental and epileptic encephalopathy (DEE) and the phenotypic spectrum of SRCAP variants.

Methods

Trio‐based whole‐exome sequencing was performed on patients with DEE from the China Epilepsy Gene 1.0 Project Cohort. Additional cases were screened from other subcohorts. The gene–disease association was validated by minor allele frequency (MAF), damaging effect of variants, genotype–phenotype correlation, and studies on spatial–temporal and single‐cell expression.

Results

De novo heterozygous SRCAP variants were identified in five patients with DEE. These variants were truncations or missense variants of severe damage characterized by significant changes in hydrophobicity and protein stability/hydrogen bonding. Additional SRCAP variants were identified in six patients with focal epilepsy (FE), including refractory FE. These variants were characterized by biallelic variants of mild damage, such as in‐frame indel or missense with fewer changes in hydrophobicity and protein stability/hydrogen bonding, which were correlated with the severity of phenotype and outcomes. The epilepsy‐associated variants presented statistically lower MAF than benign variants, with the lowest MAF in DEE‐associated variants. Compared to EP400 , SRCAP presented higher expression in the brain throughout the lifespan. In the late developmental brain, EP400 is predominantly expressed in excitatory neurons, in contrast to the higher proportion of SRCAP expression in inhibitory neurons, explaining the association of SRCAP variants with DEE and refractory FE. Significance SRCAP is associated with epilepsy and DEE. The phenotypic spectrum ranges from DEE/multisystem developmental disorders to FE of varied severity, depending on the damage of variants. The development‐dependent expression pattern of neuron specificity explains the underlying mechanism of epilepsy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyHumansMaleFemalePhenotypeChildChild, PreschoolGenetic Association StudiesExome SequencingAdolescentInfantCohort StudiesGenetic Variation

Stichwörter der Autor:innen

SRCAPde novo variantsdevelopmental and epileptic encephalopathygenetic‐dependent quantitygenotype–phenotype correlations

Autor:innen und Institutionen

  • Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and Ministry of Education of China, Second Affiliated Hospital, Guangzhou Medical University,…
  • Department of Neurosurgery, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.
  • Epilepsy Center, Guangdong 999 Brain Hospital, Guangzhou, China.
  • Department of Pediatrics, Shantou Chaonan Minsheng Hospital, Shantou, China.

ORCID-Profile: Xiao-Yu Liang, Xiang-Hong Meng, Wu-Chen Wu, Sheng Luo, Peng-Yu Wang, Dong-Ming Zhang, Zi-Sheng Lin, Jin-Jie Liang, Su-Li He, Bing-Mei Li, Jie Wang, Yong-Hong Yi, Na He, Wei-Ping Liao

Förderung

  • National Natural Science Foundation of China
  • Multi-center Clinical Research Fund Project of the Second Affiliated Hospital of Guangzhou Medical University
  • Sanming Project of Medicine in Shenzhen "Multidisciplinary epilepsy diagnosis and treatment team of Prof.Wang Yuping from Xuanwu Hospital Capital Medical Unive…
  • Stable Support Project of Shenzhen

Zitieren

APA

Liang, X. Y., Meng, X. H., Wu, W. C., Guo, J., Luo, S., Wang, P. Y., Zhang, D. M., Lin, Z. S., Liang, J. J., He, S. L., Li, B. M., Wang, J., Yi, Y. H., He, N., Liao, W. P., & China Epilepsy Gene 1.0 Project (2026). De novo SRCAP variants cause developmental and epileptic encephalopathy and the phenotypic spectrum. Epilepsia. https://doi.org/10.1111/epi.18695

Vancouver

Liang XY, Meng XH, Wu WC, Guo J, Luo S, Wang PY, et al. De novo SRCAP variants cause developmental and epileptic encephalopathy and the phenotypic spectrum. Epilepsia. 2026. doi:10.1111/epi.18695

BibTeX
@article{Liang2026,
  author = {Liang, Xiao-Yu and Meng, Xiang-Hong and Wu, Wu-Chen and Guo, Jing and Luo, Sheng and Wang, Peng-Yu and Zhang, Dong-Ming and Lin, Zi-Sheng and Liang, Jin-Jie and He, Su-Li and Li, Bing-Mei and Wang, Jie and Yi, Yong-Hong and He, Na and Liao, Wei-Ping and China Epilepsy Gene 1.0 Project, China Epilepsy Gene 1.0 Project},
  title = {De novo SRCAP variants cause developmental and epileptic encephalopathy and the phenotypic spectrum},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1111/epi.18695}
}
Kostenlos starten →